摘要
目的 :探讨经尿道前列腺等离子汽化切除术 (TUPVP)后前列腺偶发癌的诊断和治疗。 方法 :对 134例良性前列腺增生患者行TUPVP ,术后的组织标本采用连续切片法作常规病理检查。 结果 :134例TUPVP术后的前列腺标本中共检出前列腺癌 15例 ,检出率为 11.2 %。 4例A2 期患者行双侧睾丸切除术加内分泌治疗 ,9例A1期患者行内分泌治疗。除 2例术后没有任何治疗的患者失访外 ,其余 13例患者随访 7～ 15个月 ,全部存活 ,血清前列腺特异性抗原 (PSA)为 0 .15～ 4 .0 μg/L。 结论 :TUPVP术对前列腺组织的破坏小 ,术后标本多部位连续病理切片 ,可提高前列腺偶发癌的检出率 ,A1期患者可仅行内分泌治疗 ,A2 期患者应加双侧睾丸切除。
Objective: To investigate the diagnosis and treatment of incidental prostate cancer(IPC) following transurethral plasmakinetic vaporization prostatectomy(TUPVP). Methods: Pathological examinations were conducted on 134 benign prostate hyperplasia specimens by means of series microtomy after TUPVP. Results: Fifteen cases of IPC were detected from the total number of TUPVP specimens, with a pick-up rate of 11.2% . Dual testicle resection with endocrine therapy was performed in 4 cases of Stage A 2 patients, and endocrine therapy alone was conducted in 9 cases of Stage A 1 patients. Thirteen patients were followed up for 7 to 15 months and all lived without cancer(PSA 0.15～ 4.0 μg/L). Conclusion: TUPVP and series microtomy may be helpful to the dignosis of IPC. Patients at Stage A 1 need mere endocrine therapy, while those at Stage A 2 warrant dual testicle resection.
出处
《中华男科学杂志》
CAS
CSCD
2004年第11期849-850,854,共3页
National Journal of Andrology
